仙贞片对肾虚血瘀Ⅱ型糖尿病患者红细胞SOD、血清LPO及血脂、血糖的影响

Impact of Xian Zhen Tablet on Erythrocytic SOD, Serum LPO. Blood Lipidsand Glucose in Diabetes Mellitus of Kideny-deficiency-Blood-stasis Type II

68例肾虚血瘀Ⅱ型糖尿病患者,采用配对随机分组法,分为治疗组(仙贞片组),对照组(安慰剂组)。观察仙贞片对该型患者红细胞超氧化物歧化酶(RBC—SOD)活性和含量、血清过氧化脂质(LPO)、血脂、血糖以及临床症状的影响。结果病例组较健康对照组SOD活性低下,LPO含量升高,均有显著差异(P<0.05)。仙贞片治疗后RBC—SOD含量升高(P<0.001),血清LPO含量降低(P<0.05),HDL-C含量升高(P<0.05),血糖下降(P<0.05),肾虚症状明显改善,而对照组无明显变化。

68 such cases of diabetes were randomly divided into treating group (Xianzhen Tablet), control group (placebo). Indices on activity and contents of RBC -SOD, LPO, blood lipids, blood glucose, and clinical symptoms were examined. Results revealed that decreased activity of SOD, increased LPO content were more remarkable in the treating group, with significant difference (P<0. 05). At the same time, for the treating group, RBC -SOD content was increased (P <0. 001), serum LPO lowered (P< 0. 05), HDL-C contents increased (P<0. 05), and blood glucose decreased (P<0. 05), and the symptoms of kidney deficiency were also markedly mitigated; while for those in the control group, these changes were not obvious.